FIGURE

Figure 6

ID

ZDB-FIG-221214-133

Publication

Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation

Other Figures

All Figure Page

Back to All Figure Page

Figure 6

Effect of MitoTEMPO on doxorubicin-induced osteoclast differentiation and oxidative stress markers. RAW264.7 cells were cultured for 4 days with M-CSF (30 ng/mL) and RANKL (50 ng/mL) and treated with MitoTEMPO (MT) and Doxorubicin (DOX) alone or together. Levels of expression for Oc-stamp (A), Rank (B), Trap (C), Ctsk (D), Nfatc1 (E), Nf-kb p105 (F), FoxM1 (G), Sod1 (H) and Nrf 2 (I) were analyzed by qPCR. One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05, **—p ≤ 0.01, ***—p ≤ 0.001, ****—p ≤ 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.